Author: user

First look KKR’s Fortifi has been bolstered with 16 add-on acquisitions and  is present across 33 sites (Image: Getty) ‘Ripe for automation’ – Inside KKR’s food processing play “Food is not an easy thing to automate because it’s natural and it’s amorphous,” KKR partner Joshua Weisenbeck tells Agri Investor. “It’s not like a piece of metal that is the same every time. You really need more advanced technology, vision systems, more advanced robotics and software to automate.” KKR has a history of agricultural investment – through both impact and credit strategies – but its latest food sector effort comes from its flagship…

Read More

Image source: Getty Images Among all its peers in the FTSE 100, Phoenix Group (LSE:PHNX) shares take the crown when it comes to dividend yield. The evolving insurance enterprise offers a massive payout of 8.3%, enabling investors to instantly unlock a pretty substantial hands-free income stream overnight. What’s more, if analyst projections are accurate, today’s chunky yield could be set to grow even further over the next couple of years. So how much money could investors start earning if they buy 750 shares today for £4,930? Calculating income Last month, the company paid its final dividend for its 2024 fiscal…

Read More

Image source: Getty Images I generally tend to steer clear of really cheap UK stocks. That’s because they’re often cheap for a reason. I do own a few value stocks in my portfolio though. Here’s the cheapest of them… A dirt-cheap stock The stock with the lowest valuation in my portfolio today (by a wide margin) is JD Sports Fashion (LSE: JD.). It’s a retailer of athletic footwear and clothing that operates globally. Currently, it trades for around 76p. Given that City analysts expect the company to generate earnings per share of 11.8p for the financial year ending 31 January…

Read More

Image source: Getty Images FTSE 100 pharmaceutical giant GSK (LSE: GSK) is down 10% from its 10 September 12-month high of £16.77. One reason for this is the possibility of further tariffs imposed by the US on pharmaceutical imports. This has not happened so far, but it does remain a risk for the firm. That said, GSK highlighted in its 30 April Q1 results that it has identified options to mitigate any supply chain risks. Also negatively affecting the share price has been litigation connected to the alleged side effects of its Zantac drug. The firm agreed last October to pay…

Read More

Trump summons Fed’s Powell to tell him he’s wrong on ratesU.S. President Donald Trump called Federal Reserve Chair Jerome Powell to the White House on May 29 for their first face-to-face meeting since he took office in January and told the central bank chief he was making a “mistake” by not lowering interest rates.This week’s Federal Reserve meeting isn’t expected to pack much drama.With uncertainty about the impact of President Donald Trump’s tariffs on inflation and the economy still elevated, the Fed is expected to leave its key interest rate unchanged for a fourth straight meeting. It may, though, pare…

Read More

Image source: Getty Images Persimmon’s (LSE: PSN) share price has fallen 19% from its 16 October one-year high of £17.21. This does not necessarily mean that it is a bargain though. It could be that the underlying business is just worth less than it was before. However, it might be that the market has failed to fully factor into the share price the true value of the business. I took a deep dive into Persimmon’s business and its share price to find out which is the case here. How does the underlying business look? For a long time, UK housebuilders…

Read More

Image source: Getty Images Aviva (LSE:AV.) shares currently have the 12th highest dividend yield in the FTSE 100. Being an insurance giant, it’s not a particularly exciting enterprise compared to disruptive technology start-ups or novel biotechs. But boring can often be lucrative, especially when operations are highly cash-generative. In a higher interest rate environment, Aviva’s business has been able to thrive, with cash flows heading on an upward trajectory over the last five years. That’s paved the way for lower debt on the balance sheet as well as continuous dividend hikes since 2019. And patient shareholders have been rewarded with…

Read More

Image source: Getty Images FTSE shares have been making headlines lately after the UK’s main index hit record highs last week. However, not all industries are doing well in 2025. Due to a combination of trade tariffs and supply chain disruptions, transportation’s down 6.28% this year and the consumer durables sector’s off 1.5%. Leading the positive pack however, is the non-energy minerals sector, up 14.4% — outpacing tech, manufacturing and health. What are non-energy minerals? Non-energy minerals include any precious metals and rare earth minerals that are mined for uses other than energy. Examples include gold, silver, copper, zinc —…

Read More

With abundant biomass and lower production costs, India and the Global South are emerging as powerhouses in the biochar carbon market — but credibility, equity, and scale are still in questionCan biochar, a form of charcoal, provide a viable means of carbon capture to help India meet its emission goals? The experience of the pastoral nomads of Kachchh in Gujarat suggests that the answer could be yes.In agricultural circles, biochar has been described as ‘black gold’ due to its dramatic beneficial effects on soils and plant growth. It is a carbon-rich material formed by slow pyrolysis— heating biomass under an…

Read More

Image source: The Motley Fool As chairman and chief executive of Berkshire Hathaway, Warren Buffett’s been the driving force behind the company’s remarkable growth over the past six decades. But in 2021, 2022 and 2024, the company’s performance failed to beat that of the S&P 500. Could this be a sign that the American billionaire’s lost his way? I don’t think so. Patience is a virtue That’s because an investment horizon of four years is insufficient to make a sensible judgement. It’s the long term that counts. Personally, I think a 10-year period is reasonable when assessing a particular investment…

Read More